Compounds > tetradecanoylphorbol acetate
Page last updated: 2024-08-23

tetradecanoylphorbol acetate and pioglitazone

tetradecanoylphorbol acetate has been researched along with pioglitazone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's5 (71.43)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imamura, T; Kobayashi, M; Morioka, H; Sawa, T; Takada, Y; Takata, Y; Yang, GH1
Inoue, I; Katayama, S; Komoda, T; Miyazaki, T; Negishi, K; Sonoda, M; Takahashi, K1
Kitahara, M; Naitoh, T; Tsuruzoe, N1
Ando, K; Chiba, Y; Fujita, T; Ogita, T1
Ito, H; Kinoshita, M; Matsumori, A; Nakano, A1
Hirakata, M; Imura, Y; Sugiyama, Y; Tozawa, R1
Ge, H; Guo, BS; He, B; He, Q; Wang, BY; Wang, CQ; Zhang, JF1

Other Studies

7 other study(ies) available for tetradecanoylphorbol acetate and pioglitazone

ArticleYear
Pioglitazone attenuates the inhibitory effect of phorbol ester on epidermal growth factor receptor autophosphorylation and tyrosine kinase activity.
    Biochimica et biophysica acta, 1996, Jun-05, Volume: 1312, Issue:1

    Topics: Carcinoma, Squamous Cell; ErbB Receptors; Humans; Hypoglycemic Agents; Phosphorylation; Pioglitazone; Protein Kinase C; Protein Tyrosine Phosphatases; Receptor Protein-Tyrosine Kinases; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Tumor Cells, Cultured

1996
Troglitazone has a scavenging effect on reactive oxygen species.
    Biochemical and biophysical research communications, 1997, Jun-09, Volume: 235, Issue:1

    Topics: Antioxidants; Chromans; Cytochrome c Group; Dimethyl Sulfoxide; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Humans; Hydrogen Peroxide; Iron; Molecular Structure; Neutrophils; Pioglitazone; Reactive Oxygen Species; Spin Labels; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Troglitazone; Vitamin E; Xanthine; Xanthine Oxidase; Xanthines

1997
The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
    Cell biology and toxicology, 2000, Volume: 16, Issue:2

    Topics: Antineoplastic Agents; Carcinogens; Cell Survival; Cells, Cultured; Chromans; Humans; Hypoglycemic Agents; Ligands; Monocytes; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Necrosis Factor-alpha

2000
PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells.
    Biochemical and biophysical research communications, 2001, Aug-24, Volume: 286, Issue:3

    Topics: Animals; Arteriosclerosis; Cattle; Cells, Cultured; Chromans; Drug Antagonism; Endothelium; Immunohistochemistry; Pioglitazone; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Receptors, Oxidized LDL; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone; Tumor Necrosis Factor-alpha

2001
Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model.
    Laboratory investigation; a journal of technical methods and pathology, 2003, Volume: 83, Issue:12

    Topics: Animals; Chemokine CCL2; Disease Models, Animal; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Macrophage Activation; Macrophages; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Pioglitazone; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transcription Factors

2003
Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation.
    Biochemical and biophysical research communications, 2004, Oct-22, Volume: 323, Issue:3

    Topics: Cell Differentiation; Cell Line; Cholesterol; Dose-Response Relationship, Drug; Foam Cells; Homeostasis; Humans; Hypoglycemic Agents; Macrophages; Pioglitazone; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones

2004
Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma.
    Vascular pharmacology, 2007, Volume: 46, Issue:2

    Topics: Anilides; Anti-Inflammatory Agents, Non-Steroidal; Basigin; Cell Differentiation; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; I-kappa B Proteins; Macrophages; Matrix Metalloproteinase 9; Monocytes; NF-kappa B; Phosphorylation; Pioglitazone; PPAR gamma; Promoter Regions, Genetic; Resveratrol; Stilbenes; Tetradecanoylphorbol Acetate; Thiazolidinediones; Time Factors; Transfection; Tumor Necrosis Factor-alpha; U937 Cells

2007